HCA
HCA Healthcare, Inc
HCA Healthcare, Inc historical holders
total: 11
Viking Global Investors HCA Healthcare, Inc transactions over time
- Total transactions:
- 22
- New positions:
- 5
- Sold out:
- 4
- Added:
- 7
- Reduced:
- 6
- Held since:
- 2023 Q4
- Held for:
- 10 quarters
- Latest activity:
- 2026 Q1
Ole Andreas Halvorsen has been an institutional investor in HCA Healthcare, Inc (HCA) since 2013 Q3. According to 2026 Q1 report, Ole Andreas Halvorsen holds 1,075,133 shares with a market value of roughly $508.80M representing 1.42% of their equity portfolio. The fund/company first acquired HCA in 2013 Q3, initially purchasing about 2.78M shares. Ole Andreas Halvorsen later completely sold out the position and reinvested in HCA again in 2023 Q4. Since the initial investment, Viking Global Investors has made 21 more transactions in this position.
Does Ole Andreas Halvorsen still hold HCA?
Yes, Ole Andreas Halvorsen continues to hold HCA Healthcare, Inc (HCA). According to their 2026 Q1 report, they maintain a position of 1,075,133 shares valued at approximately $508.80M, representing 1.42% of their equity portfolio.
When did Ole Andreas Halvorsen first invest in HCA?
Ole Andreas Halvorsen first invested in HCA Healthcare, Inc (HCA) in 2013 Q3 at the reported quarter-end price of $42.75 per share, acquiring 2,783,331 shares in their initial purchase.
What is Ole Andreas Halvorsen's average cost basis for HCA?
Based on historical transaction data, Ole Andreas Halvorsen's estimated cost basis for HCA Healthcare, Inc (HCA) is approximately $327.95 per share. This represents their average reported price* across all buy transactions.
Has Ole Andreas Halvorsen reinvested in HCA after selling?
Yes, Ole Andreas Halvorsen has shown renewed interest in HCA Healthcare, Inc (HCA). After completely selling their position, they reinitiated an investment in 2023 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $327.95
- Weighted AVG sell price:
- $423.73
HCA transactions history by Viking Global Investors
22 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
1.42%
|
1,075,133
|
$473.24
|
$508,795,941
|
+7.60% (+75,953)
|
+0.1%
|
|
2025 Q4
|
1.24%
|
999,180
|
$466.86
|
$466,477,175
|
-27.63% (-381,403)
|
-0.46%
|
|
2025 Q3
|
1.53%
|
1,380,583
|
$426.20
|
$588,404,475
|
-26.26% (-491,550)
|
-0.61%
|
|
2025 Q2
|
2.07%
|
1,872,133
|
$383.10
|
$717,214,152
|
+58.47% (+690,773)
|
+0.77%
|
|
2025 Q1
|
1.30%
|
1,181,360
|
$345.55
|
$408,218,948
|
+6.41% (+71,130)
|
+0.08%
|
|
2024 Q4
|
1.08%
|
1,110,230
|
$300.15
|
$333,235,535
|
+59.05% (+412,200)
|
+0.4%
|
|
2024 Q3
|
1.03%
|
698,030
|
$406.43
|
$283,700,333
|
+6.71% (+43,863)
|
+0.06%
|
|
2024 Q2
|
0.81%
|
654,167
|
$321.28
|
$210,170,774
|
+23.57% (+124,766)
|
+0.15%
|
|
2024 Q1
|
0.66%
|
529,401
|
$333.53
|
$176,571,116
|
-27.00% (-195,815)
|
-0.24%
|
|
2023 Q4
|
0.72%
|
725,216
|
$270.68
|
$196,301,467
|
new
|
+0.72%
|
|
2021 Q2
|
0.00%
|
$188.34
|
-100% (-1,498,742)
|
|||
|
2021 Q1
|
0.84%
|
$188.34
|
-14.27% (-249,452)
|
|||
|
2020 Q4
|
0.79%
|
$164.46
|
new
|
|||
|
2016 Q3
|
0.00%
|
$77.01
|
-100% (-1,089,482)
|
|||
|
2016 Q2
|
0.36%
|
$77.01
|
new
|
|||
|
2015 Q2
|
0.00%
|
$75.23
|
-100% (-1,016,617)
|
|||
|
2015 Q1
|
0.30%
|
$75.23
|
-73.74% (-2,854,037)
|
|||
|
2014 Q4
|
1.30%
|
$73.39
|
+115.66% (+2,075,874)
|
|||
|
2014 Q3
|
0.51%
|
$70.52
|
new
|
|||
|
2014 Q1
|
0.00%
|
$47.71
|
-100% (-2,654,617)
|
|||
|
2013 Q4
|
0.59%
|
$47.71
|
-4.62% (-128,714)
|
|||
|
2013 Q3
|
0.66%
|
$42.75
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.